Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis.

Kuwabara H, Fukuda A, Tsuda Y, Shibayama Y.

Clin Rheumatol. 2013 Mar;32 Suppl 1:S47-9. doi: 10.1007/s10067-010-1438-y. Epub 2010 Apr 9.

PMID:
20379839
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis.

Hagiyama H, Kubota T, Komano Y, Kurosaki M, Watanabe M, Miyasaka N.

Clin Exp Rheumatol. 2004 May-Jun;22(3):375-6. Review. No abstract available.

PMID:
15144137
[PubMed - indexed for MEDLINE]
3.

Severe hepatitis linked to B virus infection after withdrawal of low dose methotrexate therapy.

Narváez J, Rodriguez-Moreno J, Martinez-Aguilá MD, Clavaguera MT.

J Rheumatol. 1998 Oct;25(10):2037-8. No abstract available.

PMID:
9779869
[PubMed - indexed for MEDLINE]
4.

Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient.

Ito S, Nakazono K, Murasawa A, Mita Y, Hata K, Saito N, Kikuchi M, Yoshida K, Nakano M, Gejyo F.

Arthritis Rheum. 2001 Feb;44(2):339-42.

PMID:
11229464
[PubMed - indexed for MEDLINE]
Free Article
5.

Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy.

Lee YH, Bae SC, Song GG.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1):118-21. Epub 2012 Oct 30. Review.

PMID:
23111095
[PubMed - indexed for MEDLINE]
6.

Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.

Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS.

Ann Rheum Dis. 2011 Oct;70(10):1719-25. doi: 10.1136/ard.2010.148783. Epub 2011 Jun 29.

PMID:
21719446
[PubMed - indexed for MEDLINE]
7.

Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate.

Watanabe K, Takase K, Ohno S, Ideguchi H, Nozaki A, Ishigatsubo Y.

Mod Rheumatol. 2012 Jun;22(3):470-3. doi: 10.1007/s10165-011-0521-9. Epub 2011 Sep 8.

PMID:
21901356
[PubMed - indexed for MEDLINE]
8.

Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.

Tamori A, Koike T, Goto H, Wakitani S, Tada M, Morikawa H, Enomoto M, Inaba M, Nakatani T, Hino M, Kawada N.

J Gastroenterol. 2011 Apr;46(4):556-64. doi: 10.1007/s00535-010-0367-5. Epub 2011 Jan 19.

PMID:
21246383
[PubMed - indexed for MEDLINE]
9.

Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate.

Ostuni P, Botsios C, Punzi L, Sfriso P, Todesco S.

Ann Rheum Dis. 2003 Jul;62(7):686-7. No abstract available.

PMID:
12810441
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease.

Michel M, Duvoux C, Hezode C, Cherqui D.

J Rheumatol. 2003 Jul;30(7):1624-5.

PMID:
12858469
[PubMed - indexed for MEDLINE]
11.

Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B.

Friedt M, Gerner P, Lausch E, Trübel H, Zabel B, Wirth S.

Hepatology. 1999 Apr;29(4):1252-8.

PMID:
10094972
[PubMed - indexed for MEDLINE]
12.

A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximab-reactivated hepatitis B.

Tsuboi H, Tsujii A, Nampei A, Yoshihara H, Kawano K, Takeuchi E, Shi K.

Mod Rheumatol. 2011 Dec;21(6):701-5. doi: 10.1007/s10165-011-0470-3. Epub 2011 May 29.

PMID:
21626075
[PubMed - indexed for MEDLINE]
13.

Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient.

Mo N, Muthu S, O'Sullivan M.

Rheumatology (Oxford). 2011 Apr;50(4):808-10. doi: 10.1093/rheumatology/keq417. Epub 2010 Dec 22. No abstract available.

PMID:
21183450
[PubMed - indexed for MEDLINE]
Free Article
14.

Detection of precore/core-mutant hepatitis B virus genome in patients with acute or fulminant hepatitis without serological markers for recent HBV infection.

Uchida T, Aye TT, Becker SO, Hirashima M, Shikata T, Komine F, Moriyama M, Arakawa Y, Takase S, Mima S.

J Hepatol. 1993 Jul;18(3):369-72.

PMID:
8228132
[PubMed - indexed for MEDLINE]
15.

Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection.

Carroll MB, Bond MI.

Semin Arthritis Rheum. 2008 Dec;38(3):208-17. doi: 10.1016/j.semarthrit.2007.10.011. Epub 2008 Jan 25. Review.

PMID:
18221983
[PubMed - indexed for MEDLINE]
16.

Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment.

Gérolami R, Henry M, Borentain P, Colson P, Botta D, Tamalet C.

Clin Infect Dis. 2005 Feb 15;40(4):e24-7. Epub 2005 Jan 21.

PMID:
15712066
[PubMed - indexed for MEDLINE]
Free Article
17.

Reactivation of latently infected hepatitis B virus in a leukemia patient with antibodies to hepatitis B core antigen.

Marusawa H, Imoto S, Ueda Y, Chiba T.

J Gastroenterol. 2001 Sep;36(9):633-6.

PMID:
11578069
[PubMed - indexed for MEDLINE]
18.

Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs.

Mori S.

Mod Rheumatol. 2011 Dec;21(6):621-7. doi: 10.1007/s10165-011-0458-z. Epub 2011 Apr 29.

PMID:
21528424
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN; Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

N Engl J Med. 2000 Nov 30;343(22):1594-602.

PMID:
11096166
[PubMed - indexed for MEDLINE]
Free Article
20.

Precore mutant hepatitis B virus infection and liver disease.

Naoumov NV, Schneider R, Grötzinger T, Jung MC, Miska S, Pape GR, Will H.

Gastroenterology. 1992 Feb;102(2):538-43.

PMID:
1732124
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk